Clinical Trials Browser

Phase 4 × Uterine Cervical Dysplasia × Gynecologic × Clear all

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia, Papillomavirus Infections

NCT03629886 2024-03-15

Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study

Phase 4 Completed

6,051 enrolled 11 charts

Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT05426148 2022-06-29

Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female

Phase 4 Completed

540 enrolled

Gynecologic

Persistent Infection, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections

NCT01544478 2018-11-28

V501 Safety and Efficacy Study in Japanese Women Aged 16 to 26 Years (V501-110)

Phase 4 Completed

1,030 enrolled 5 charts

Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Adenocarcinoma in Situ

NCT02629510 2017-05-31

TACO

Phase 4 Unknown

268 enrolled

Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT01034358 2012-10-23

Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease

Phase 4 Completed

15 enrolled 6 charts

Gynecologic

Uterine Cervical Dysplasia, Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases

NCT00842738 2010-01-14

Can Alternative Treatment Have an Impact on Cervical Dysplasia?

Phase 4 Unknown

200 enrolled

Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT00733109 2010-01-11

CIN2

Phase 4 Completed

90 enrolled

Gynecologic

Uterine Cervical Dysplasia

Clinical Trials

AGO-Gard

Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study

Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female

V501 Safety and Efficacy Study in Japanese Women Aged 16 to 26 Years (V501-110)

TACO

Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease

Can Alternative Treatment Have an Impact on Cervical Dysplasia?

CIN2